Skip to content

Analysis of the efficacy and prognosis of DTI-assisted stereotactic minimally invasive puncture-and-drainage-based surgery in elderly patients with moderate-volume hypertensive thalamo-basal ganglia area cerebral haemorrhage

Analysis of the efficacy and prognosis of DTI-assisted stereotactic minimally invasive puncture-and-drainage-based surgery in elderly patients with moderate-volume hypertensive thalamo-basal ganglia area cerebral haemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079252
Enrollment
Unknown
Registered
2023-12-28
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive cerebral hemorrhage

Interventions

DTI-assisted stereotactic minimally invasive puncture-based surgery group:None
Conservative treatment with conventional drugs group:None

Sponsors

The First People's Hospital of Yibin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 50-80 years old; complete clinical data; meeting the diagnostic criteria in the Chinese Multidisciplinary Diagnostic and Treatment Guidelines for Hypertensive Cerebral Haemorrhage; haematoma volume of 15-40 mL; first onset of illness; all admitted to the hospital within 24 h of onset of illness; Glasgow Coma Scale (GCS) score of 8-15; and normal coagulation function.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1, combined with cerebral hernia and bilateral pupil dilatation at the time of admission; 2, trauma, vascular malformation, intracranial aneurysm, tumour, stroke, etc. caused by other factors of cerebral haemorrhage; 3, combined with a large number of intraventricular haemorrhage and hydrocephalus, who are unsuitable for conservative or minimally invasive treatment; 4, combined with cardiac, hepatic, pulmonary, renal insufficiency, haematological disorders, and other serious basic diseases; 5, combined with coagulation disorders; 6, who have already occurred cerebral death; 7, combined with respiratory failure, pupil dilatation, and deafferented brain patients; 8, patients with expression disorders, poor compliance, or psychiatric disorders; 9, patients who transferred to another hospital in mid-stream or who ceased treatment.

Design outcomes

Primary

MeasureTime frame
Ability to perform daily living skills scores;

Secondary

MeasureTime frame
ADC value, FA value in DTI;cytokines level;Incidence of complications;NHISS;Operative time;

Countries

China

Contacts

Public ContactShiqiang Yang

The First People's Hospital of Yibin

xiaoyangshiqiang@163.com+86 183 8316 5792

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026